Table 1.
HC (n=22) | PD exp 1 (n=12) | PD exp 2 (n=11) | |
---|---|---|---|
Sample Size (N) | 22 | 12 | 11 |
Age (years) | 63.9(1.6) | 59.3(2.9) | 58.9(2.6) |
Gender (M: F)** | 12:10 | 8:4 | 6:5 |
Education (years) | 14.5(.7) | 13.7(.6) | 13.7(.7) |
MMSE | 29.4(.2) | 28.9 (.35) | 28.6 (.4) |
CESD | 7 | 14.9 (2.5) | |
BDI-II | – | 9.8 (1.7) | |
LEDD | – | 670.9(184.9) | 500.9 (127.8) |
Disease Duration (years) + | – | 11.8(1.8) | 12.9 (1.7) |
UPDRS dorsal | – | – | 30.9 (2.8) |
UPDRS ventral | – | – | 30.1(3.4) |
UPDRS chronic | – | 25.0 (3.76) n=9 | – |
UPDRS acute | – | 24.11 (3.69) n=9 | – |
UPDRS OFF | – | 31.66 (3.99) n=9 | – |
MMSE=Mini Mental State Examination, CESD=Center for Epidemiologic Studies Depression Scale, BDI-II=Beck Depression Inventory II, UPDRS=Unified Parkinson’s Disease Rating Scale Motor, LEDD=Levodopa Daily Dosis